Skip to main content
Premium Trial:

Request an Annual Quote

CuraGen Plans to Raise $75M in Private Placement

NEW YORK, Feb. 10 (GenomeWeb News) - CuraGen today said that it plans to raise $75 million in a private placement of convertible subordinated notes due in 2011.

CuraGen said it would grant the initial purchaser of the notes an option to purchase up to an additional $15 million aggregate principal amount of the notes.

The company said it plans to use a portion of the net proceeds to repay its existing debt, and the remainder for working capital, general corporate purposes, and possibly for future acquisitions of complementary businesses or technologies.

CuraGen has subordinated convertible debt of $150 million due in February of 2007. The company last week reported that it held cash and investments of $343.6 million as of Dec. 31, 2003.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.